Synopsys INC Form 4 insider transactions

Synopsys Chief Revenue Officer Michael Ellow acquired 5,128 shares through RSU vesting and disposed of 2,543 shares for tax obligations.

Synopsys General Counsel Janet Lee acquired 540 shares via RSU vesting and withheld 235 shares for tax obligations.

Deputy CFO and CAO Sudhindra Kankanwadi acquired 720 shares of Synopsys common stock via RSU vesting and disposed of 249 shares for tax obligations.

Synopsys CFO Shelagh Glaser acquired 1,259 shares via restricted stock unit vesting and withheld 436 shares for tax obligations.

Synopsys CEO Sassine Ghazi exercised stock options and sold shares as part of a pre-arranged Rule 10b5-1 trading plan.

Executive Chair Aart de Geus acquired 449 shares of Synopsys common stock through the vesting of restricted stock units.

Synopsys Inc. CFO Shelagh Glaser executed a Rule 10b5-1 trading plan, resulting in the sale of 3,394 shares of common stock.

Synopsys GC & Corporate Secretary Janet Lee reported transactions involving Synopsys Inc. common stock, including the acquisition of shares related to restricted stock units and tax withholding.

Director Jesse Cohn of Synopsys Inc. has reported the acquisition of common stock through an automatic award under the company's equity incentive plan.

Synopsys General Counsel Janet Lee reported the vesting of restricted stock units and a subsequent tax-related share disposition.

Synopsys Director Ravi K. Vijayaraghavan was granted 453 shares of common stock as an automatic equity incentive award.

Director Peter A. Shimer acquired 453 shares of Synopsys common stock via an automatic equity incentive plan award.

Director John Schwarz acquired 453 shares of Synopsys common stock via an automatic equity incentive plan award.

Director Jeannine Sargent was granted 453 shares of Synopsys common stock as part of an automatic equity incentive plan.

Director Robert G. Painter was granted 453 shares of Synopsys common stock as part of an automatic equity incentive plan.

Director Mercedes Johnson received an automatic equity grant of 453 shares of Synopsys common stock.

Director Bruce Chizen was granted 453 shares of Synopsys common stock as part of an automatic equity incentive plan.

Director Janice Chaffin acquired 453 shares of Synopsys common stock as part of an automatic equity incentive plan award.

Synopsys' Chief Accounting Officer, Sudhindra Kankanwadi, exercised restricted stock units and sold a portion of the resulting common stock to cover tax obligations.

Synopsys CFO Shelagh Glaser reported the vesting of 793 restricted stock units and the subsequent sale of 282 shares to cover tax obligations.

Synopsys President and CEO Sassine Ghazi reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Synopsys Executive Chair Aart de Geus reported the acquisition of 1,763 shares of common stock through RSU vesting and the disposition of 630 shares for tax obligations.

Synopsys General Counsel Janet Lee reported the vesting of 292 Restricted Stock Units and the subsequent disposition of 127 shares for tax withholding purposes.

Synopsys Inc. Director Peter A. Shimer was granted 925 shares of common stock through an automatic equity award plan.

Synopsys' General Counsel and Corporate Secretary, Janet Lee, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax obligations.

Synopsys Executive Chair Aart de Geus has a pre-planned acquisition of 28 shares of common stock through an employee stock purchase plan set for February 27, 2026.

Synopsys CFO Shelagh Glaser reported a planned acquisition of 28 shares of common stock at $351.90 per share through an employee stock purchase plan.

Synopsys President and CEO Sassine Ghazi is scheduled to acquire 28 shares of common stock at $351.90 per share through an employee stock purchase plan.

Synopsys Chief Accounting Officer Sudhindra Kankanwadi acquired 28 shares of common stock through an employee stock purchase plan.

Synopsys General Counsel Janet Lee sold 250 shares of common stock at $530 per share, executed under a pre-arranged 10b5-1 plan.